Biohit Oyj - Annual report/ annual accounts

Publication of Biohit Oyj Annual Report 2012

Biohit Oyj March 18, 2013 at 11:30 local time (EET)



Biohit Oyj's Annual Report 2012 is published today as PDF document. The annual
report contains a review of information published in 2012. 

Report is available in English and Finnish at Biohit company website
www.biohithealthcare.com/investors. Printed publication of Annual Report 2012
will be distributed to shareholders in Annual General Meeting. 



Additional information:

CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
semi.korpela@biohit.fi
www.biohithealthcare.com



Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology established in 1988.
Biohit's mission is “Innovating for Health”. The purpose of the company is to
take social responsibility and produce innovation, new technologies and
analysis systems for use in medicine, research institutions and industry,
helping to promote research and diagnostics and to improve the quality of life
of people by means of preventing disease, human suffering and financial loss.
We are committed to responsibility and it is our duty to innovate and develop
the marketing and availability of our products and services. Biohit is
headquartered in Helsinki and its subsidiaries are located China and UK. Since
1999, Biohit's Series B shares (BIOBV) have been listed in the NASDAQ OMX
Helsinki Oy Small cap/Healthcare sector.

Attachments:

Biohit_VSK_2012_EN_net.pdf